Hoddinott G - Search Results

1

Opportunities for Mobile App-Based Adherence Support for Children With Tuberculosis in South Africa.

Morse RM, Myburgh H, Reubi D, Archey AE, Busakwe L, Garcia-Prats AJ, Hesseling AC, Jacobs S, Mbaba S, Meyerson K, Seddon JA, van der Zalm MM, Wademan DT, Hoddinott G. Morse RM, et al. Among authors: hoddinott g. JMIR Mhealth Uhealth. 2020 Nov 11;8(11):e19154. doi: 10.2196/19154. JMIR Mhealth Uhealth. 2020. PMID: 33174850 Free PMC article.

2

Social science is needed to understand the impact of paediatric MDR-TB treatment on children and their families.

Hoddinott G, Hesseling AC. Hoddinott G, et al. Int J Tuberc Lung Dis. 2018 Jan 1;22(1):4. doi: 10.5588/ijtld.17.0814. Int J Tuberc Lung Dis. 2018. PMID: 29297419 No abstract available.

3

Community engagement for paediatric MDR-TB clinical trials: principles to support ethical trial implementation.

Hoddinott G, Staples S, Brown R, Simwinga M, Mubekapi-Musadaidzwa C, Hesseling AC, Hendricks G, De Koker P, McKenna L. Hoddinott G, et al. Int J Tuberc Lung Dis. 2018 May 1;22(5):40-45. doi: 10.5588/ijtld.17.0356. Int J Tuberc Lung Dis. 2018. PMID: 29665952

4

Shorter treatment for minimal tuberculosis (TB) in children (SHINE): a study protocol for a randomised controlled trial.

Chabala C, Turkova A, Thomason MJ, Wobudeya E, Hissar S, Mave V, van der Zalm M, Palmer M, Kapasa M, Bhavani PK, Balaji S, Raichur PA, Demers AM, Hoddinott G, Owen-Powell E, Kinikar A, Musoke P, Mulenga V, Aarnoutse R, McIlleron H, Hesseling A, Crook AM, Cotton M, Gibb DM; SHINE trial team. Chabala C, et al. Among authors: hoddinott g. Trials. 2018 Apr 19;19(1):237. doi: 10.1186/s13063-018-2608-5. Trials. 2018. PMID: 29673395 Free PMC article.

5

Households, fluidity, and HIV service delivery in Zambia and South Africa - an exploratory analysis of longitudinal qualitative data from the HPTN 071 (PopART) trial.

Hoddinott G, Myburgh H, de Villiers L, Ndubani R, Mantantana J, Thomas A, Mbewe M, Ayles H, Bock P, Seeley J, Shanaube K, Hargreaves J, Bond V, Reynolds L; HPTN 071 (PopART) Study Team. Hoddinott G, et al. J Int AIDS Soc. 2018 Jul;21 Suppl 4(Suppl Suppl 4):e25135. doi: 10.1002/jia2.25135. J Int AIDS Soc. 2018. PMID: 30027687 Free PMC article.

6

Levofloxacin versus placebo for the prevention of tuberculosis disease in child contacts of multidrug-resistant tuberculosis: study protocol for a phase III cluster randomised controlled trial (TB-CHAMP).

Seddon JA, Garcia-Prats AJ, Purchase SE, Osman M, Demers AM, Hoddinott G, Crook AM, Owen-Powell E, Thomason MJ, Turkova A, Gibb DM, Fairlie L, Martinson N, Schaaf HS, Hesseling AC. Seddon JA, et al. Among authors: hoddinott g. Trials. 2018 Dec 20;19(1):693. doi: 10.1186/s13063-018-3070-0. Trials. 2018. PMID: 30572905 Free PMC article.

7

Morbidity and mortality up to 5 years post tuberculosis treatment in South Africa: A pilot study.

Osman M, Welte A, Dunbar R, Brown R, Hoddinott G, Hesseling AC, Marx FM. Osman M, et al. Among authors: hoddinott g. Int J Infect Dis. 2019 Aug;85:57-63. doi: 10.1016/j.ijid.2019.05.024. Epub 2019 May 24. Int J Infect Dis. 2019. PMID: 31132472 Free article.

8

Retention in care and factors critical for effectively implementing antiretroviral adherence clubs in a rural district in South Africa.

Bock P, Gunst C, Maschilla L, Holtman R, Grobbelaar N, Wademan D, Dunbar R, Fatti G, Kruger J, Ford N, Hoddinott G, Meehan SA. Bock P, et al. Among authors: hoddinott g. J Int AIDS Soc. 2019 Oct;22(10):e25396. doi: 10.1002/jia2.25396. J Int AIDS Soc. 2019. PMID: 31588668 Free PMC article.

9

Acceptability of a first-line anti-tuberculosis formulation for children: qualitative data from the SHINE trial.

Wademan DT, Busakwe L, Nicholson TJ, van der Zalm M, Palmer M, Workman J, Turkova A, Crook AM, Thomason MJ, Gibb DM, Seeley J, Hesseling A, Hoddinott G. Wademan DT, et al. Among authors: hoddinott g. Int J Tuberc Lung Dis. 2019 Dec 1;23(12):1263-1268. doi: 10.5588/ijtld.19.0115. Int J Tuberc Lung Dis. 2019. PMID: 31931909 Free PMC article.

10

A novel approach for eliciting adolescent MDR-TB treatment tolerability: qualitative data from South Africa.

Zimri K, Casper R, Hoddinott G, Schaaf HS, Garcia-Prats AJ, Rose PC, Hesseling AC, Viljoen L. Zimri K, et al. Among authors: hoddinott g. Int J Tuberc Lung Dis. 2020 Jan 1;24(1):43-47. doi: 10.5588/ijtld.19.0207. Int J Tuberc Lung Dis. 2020. PMID: 32005306

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

114 results

Search Page